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EDITORIAL
Effect of salpingectomy on ovarian response to hyperstimulation during in vitro
fertilization: does it really matter?
Until the end of the twentieth century, the medical community
has considered salpingectomy as a trivial appendix of more com-
plex gynecological surgeries or as an “emergency” option to solve
life-threatening conditions such as ruptured ectopic tubal preg-
nancies. In the last 20 years, however, something has changed.
Salpingectomy “per se” achieved increasing consensus as a pro-
cedure which (1) can reduce the risk of serous ovarian carcin-
oma, (2) can improve IVF pregnancy rate in patients with
hydrosalpinx, and (3) represents an effective method of perman-
ent sterilization [1].
The “Kurman theory” that considers the distal Fallopian tube
as the site of origin for ovarian and peritoneal serous cancers [2]
is achieving increasing consensus, leading many national societies
to recommend consideration of prophylactic salpingectomy dur-
ing surgery for benign conditions in women who accomplished
their reproductive desire [3].
On the other side, the Practice Committee of the American
Society for Reproductive Medicine (ASRM) published in 2008 a
Committee opinion supporting the practice of salpingectomy
prior to in vitro fertilization (IVF) in patients with hydrosalpinx,
with the aim of improving pregnancy rates [4]; the recommenda-
tion was reiterated in 2015 in a Committee opinion on the role
of tubal surgery in the era of assisted reproductive technology
[5].
Hydrosalpinx adversely affect IVF outcomes, by reducing the
implantation rate and increasing the risk of miscarriage [4,5].
Among the pathogenic mechanisms proposed, embryo-toxic
effects, mechanical flushing and changes in endometrial receptiv-
ity are considered the most probable by reproductive gynecolo-
gists. According to these pathogenic theories, the rationale
behind surgical treatment of hydrosalpinx prior to IVF is to
eliminate the negative effect of the hydrosalpingeal fluid either
by aspirating it (ultrasound-guided aspiration) or by removing
the entire fallopian tubes (salpingectomy) or by isolating them
from the uterine cavity (laparoscopic or hysteroscopic proximal
occlusion).
Therefore, in tubal factor infertility, when the cause is irrepar-
able hydrosalpinx, IVF is now considered the best option rather
than attempting to restore tubal function [4,5] and tubal surgery
is recommended only to exclude the tubal content from the
endometrial cavity before an embryo try to implant inside.
Thanks to these procedures, the hydrosalpinx fluid can no
longer reach the uterine cavity and exert its toxic effect on
implantation, the most delicate phase of pregnancy. According to
this view, everybody will agree that the correct method to verify
the effectiveness of surgical treatments of hydrosalpinx (as salpin-
gectomy or tubal occlusion) compared with no intervention prior
to IVF is to evaluate the live birth rate or, at least, the clinical
pregnancy rate as the main study outcomes.
Nevertheless, in 2016, Fan and Ma [6] published their meta-
analysis aimed to compare ovarian response to hyperstimulation
during IVF between patients who underwent salpingectomy for
hydrosalpinx or for ectopic pregnancy and controls. Of the 25
studies included in the final analysis, 12 were in English and 13
in Chinese. Moreover, as correctly reported by authors, 21 stud-
ies were retrospective, and four were prospective. More relevant
is the fact that the IVF protocols were not homogeneous. Indeed,
18 studies used long protocols, three used short protocols, three
used other not-specified protocols and in one case the protocol
used was not clearly stated. This most likely reduces the value of
the total dose of gonadotropins and the duration of hyperstimu-
lation as outcomes. Finally, the basal FSH value, which is another
outcome evaluated, is currently considered the most indirect
marker of ovarian reserve, given its recognized inter and intra-
cycles variability.
The meta-analysis demonstrated that the number of oocytes
retrieved in patients who underwent salpingectomy is not signifi-
cantly different from that of the control group (IV 0.09 [95%
CI -0.20, 0.03]; p¼.15) and shows substantial evidence of hetero-
geneity (I2¼65%). Conversely, statistical significance could be
found when bilateral and unilateral salpingectomies are split into
two groups and each group is compared to controls.
Unfortunately, of the 25 studies included, the two negatively
influencing the results of these comparisons are articles published
in Chinese, for which only the abstract is available [6]. All the
other studies report not significant differences among groups for
this outcome. Therefore, the conclusion made by the Authors
that “the present study indicated that salpingectomy may impair
ovarian response” seems rather extreme.
Conversely, in 2017, another systematic review by Kotlyar
et al. [7] collected and evaluated 48 studies on women treated by
salpingectomy for any indication, in order to evaluate its effects
on ovarian function and also on pregnancy rates. According to
this review, for most indications for salpingectomy, ovarian
reserve is not affected; moreover, salpingectomy does not cause
substantial decrease in conception rates in patients attempting to
conceive naturally after the procedure and outcomes are mark-
edly improved when salpingectomy is performed for hydrosal-
pinx in the context of planned IVF [7].
These findings are consistent with those of two previous
meta-analysis on the effects of salpingectomy before IVF in
women affected by hydrosalpinx [8,9]. The two studies reported
an increased ongoing and clinical pregnancy rates with salpingec-
tomy versus no intervention (OR 2.14, 95% CI 1.23–3.73 and OR
2.31, 95% CI 1.48–3.62, respectively), an increase in clinical preg-
nancy rate with occlusion versus no intervention (OR 4.66, 95%
CI 2.47–10.01) [8] and no difference in the clinical pregnancy
rates between salpingectomy and tubal occlusion [9].
Given all these premises, it is not clear which is the rationale
of evaluating the effect of salpingectomy exclusively on ovarian
response to hyperstimulation during IVF. We find it is important
to again underline that the detrimental effect of hydrosalpinx is
exerted on the implantation stage, as is clearly confirmed by the
two-folds increased odd ratio for pregnancy in women in which
the affected tube is removed. Therefore, the real parameter which
should be evaluated is pregnancy rate.
Nevertheless, even if clear and irrefutable evidence that salpin-
gectomy significantly reduces the ovarian response to FSH
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stimulation will be inferred, this could not lead reproductive
gynecologists to advice against surgery, but to recommend to
their patients with hydrosalpinx candidate to IVF a two-stage
approach. The first stage should entail ovarian hyperstimulation,
egg collection, mature oocyte in vitro fertilization and embryo/
blastocysts freezing; the second stage would consist in salpingec-
tomy followed by thawed embryo transfer. Obviously, such an
approach could be offered only in IVF centers equipped with
modern and qualified laboratories able to ensure high success
rates in cycles with thawed blastocysts.
In the next years, all efforts should be focused on rigorous
and objective studies on long-term consequences of salpingec-
tomy, both in terms of live birth rates after IVF than in terms of
general health. In this regard, the evaluation of age at menopause
of patients treated with salpingectomy compared with controls
would be the conclusive proof of the safety of the technique.
Meanwhile, considering the recommendations of many
national societies on the opportunity to prevent ovarian cancers
through the prophylactic removal of Fallopian tubes during sur-
geries for benign pathologies [3], and considering that also in
those countries where the professional societies have not taken
an official position the available evidence and recommendations
from other countries have already changed [10–13], caution is
required in reporting any indirect and not certain negative effects
of salpingectomy.
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